Prof. Dr. med.

Marc Piroth

Chair holder

Faculty of Health (School of Medicine)  |  Chair of Radiotherapy and Radiation Oncology


Chair of Radiotherapy and Radiation Oncology


Research

Projects:

  • Assessment and reduction of patient anxiety in radiotherapy
  • Recording and reducing stress factors of employees in radiotherapy

 

Scientific focus:

  • PET-CT-adapted radiotherapy
  • Stereotactic/high-precision radiotherapy
  • Radiotherapy for breast cancer
  • Radiochemotherapy for anal cancer

Employees

  • Dr Jehad Abu-Jawad (Senior Consultant at the clinic)
  • Dr rer.-nat. Arnd Röser (Senior Medical Physicist at the clinic)
  • Mrs S. Draia (Senior Physician)
  • Mr J. Uhlik (Senior Physician)

Clinical competencies

Full spectrum of radiotherapy for malignant and benign diseases, in particular:

  • Stereotactic radiotherapy of cerebral and extracerebral tumours/metastases
  • Intensity-modulated radiotherapy (IMRT)
  • Image-guided radiotherapy (IGRT)
  • Rapid Arc (VMAT) techniques
  • Surface-guided radiotherapy
  • Markerless radiotherapy
  • Combined radiochemotherapy
  • Palliative radiotherapy
  • Intraoperative radiotherapy (IORT) for breast cancer
  • Afterloading radiotherapy (brachytherapy) for gynaecological tumours

Resume

Current position:

Professor, Head of the Department of Radiation Oncology, Helios University Hospital Wuppertal

Witten/Herdecke University

 

Academic degrees:

1998
MD; University of Düsseldorf, Germany

1999
Full licence to practice medicine

2003
Specialist in radiation oncology, University Hospital RWTH Aachen, Germany

2010
Doctoral studies, University Hospital RWTH Aachen, Germany

2017
Professor of Radiation Oncology, Helios University Hospital Wuppertal, Witten/Herdecke University, Germany

 

Publications:
see PubMed


Teaching

Lectures within POL:

  • Introduction and basics of radiotherapy part 1 and 2 (general and organ-related aspects of radiotherapy).
  • PJ lecture series "Radiotherapy live" / various current topics

Press expert for

Entire spectrum of radiotherapy for malignant and benign diseases, in particular:

  • Radiotherapy for breast cancer,
  • Radiotherapy/radiochemotherapy of brain tumours
  • New developments in radiotherapy (4D radiotherapy planning, respiratory gating, surface guidance, markerless radiotherapy)
  • Pain radiotherapy for benign diseases (e.g. arthrosis)

Further information

Memberships among others:

  • German Society for Radiooncology (Degro)
  • Member of the Degro expert panel on breast cancer
  • American Society of Clinical Oncology (ASCO)
  • German Cancer Society (DKG)
  • German Society for Haematology and Oncology (DGHO)
  • German Society for Senology (DGS)
  • Working Group for Radiological Oncology (ARO)
  • Working Group for Gynaecological Oncology (AGO)
  • German Society for Palliative Medicine (DGP)
  • American Society of Clinical Oncology (ASCO)
  • Neurooncology Working Group (NOA; Germany)